Innate immune receptors: key regulators of metabolic disease progression
- PMID: 23747246
- DOI: 10.1016/j.cmet.2013.05.011
Innate immune receptors: key regulators of metabolic disease progression
Abstract
The study of the intersection of immunology and metabolism is a growing field fueled by the increased prevalence of obesity-associated pathologies. Importantly, the capacity of the innate immune system to sense metabolic stress induced by nutritional surplus has been linked with the progression of obesity, insulin resistance, type 2 diabetes mellitus, nonalcoholic fatty liver disease, and atherosclerosis. Moreover, it is clear that the innate immune system regulates the composition of the intestinal microbiota, which impacts multiple host metabolic processes. Here we review recent studies in this emerging field with an emphasis on how innate immune receptors determine metabolic disease progression.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
-
Immunologic impact of the intestine in metabolic disease.J Clin Invest. 2017 Jan 3;127(1):33-42. doi: 10.1172/JCI88879. Epub 2017 Jan 3. J Clin Invest. 2017. PMID: 28045403 Free PMC article. Review.
-
Immunometabolism of obesity and diabetes: microbiota link compartmentalized immunity in the gut to metabolic tissue inflammation.Clin Sci (Lond). 2015 Dec;129(12):1083-96. doi: 10.1042/CS20150431. Clin Sci (Lond). 2015. PMID: 26464517 Review.
-
Innate immune activation in obesity.Mol Aspects Med. 2013 Feb;34(1):12-29. doi: 10.1016/j.mam.2012.10.002. Epub 2012 Oct 13. Mol Aspects Med. 2013. PMID: 23068074 Free PMC article. Review.
-
Diet, commensals and the intestine as sources of pathogen-associated molecular patterns in atherosclerosis, type 2 diabetes and non-alcoholic fatty liver disease.Atherosclerosis. 2011 May;216(1):1-6. doi: 10.1016/j.atherosclerosis.2011.02.043. Epub 2011 Feb 26. Atherosclerosis. 2011. PMID: 21439567 Review.
-
Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis.Hepatology. 2008 Aug;48(2):670-8. doi: 10.1002/hep.22399. Hepatology. 2008. PMID: 18666225 Free PMC article. Review.
Cited by
-
Cardiovascular disease and cancer: shared risk factors and mechanisms.Nat Rev Cardiol. 2024 Apr 10. doi: 10.1038/s41569-024-01017-x. Online ahead of print. Nat Rev Cardiol. 2024. PMID: 38600368 Review.
-
Population-enriched innate immune variants may identify candidate gene targets at the intersection of cancer and cardio-metabolic disease.Front Endocrinol (Lausanne). 2024 Mar 21;14:1286979. doi: 10.3389/fendo.2023.1286979. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38577257 Free PMC article. Review.
-
Assessment of the effectiveness of weight-adjusted antibiotic administration, for reduced duration, in surgical prophylaxis of primary hip and knee arthroplasty.World J Orthop. 2024 Feb 18;15(2):170-179. doi: 10.5312/wjo.v15.i2.170. eCollection 2024 Feb 18. World J Orthop. 2024. PMID: 38464351 Free PMC article.
-
Inhibition of Hyperglycemia and Hyperlipidemia by Blocking Toll-like Receptor 4: Comparison of Wild-Type and Toll-like Receptor 4 Gene Knockout Mice on Obesity and Diabetes Modeling.Biology (Basel). 2024 Jan 22;13(1):63. doi: 10.3390/biology13010063. Biology (Basel). 2024. PMID: 38275739 Free PMC article.
-
Risk Factors for Long COVID in Older Adults.Biomedicines. 2023 Nov 8;11(11):3002. doi: 10.3390/biomedicines11113002. Biomedicines. 2023. PMID: 38002002 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
